Quick Answer
On May 13, 2026, the Centers for Medicare and Medicaid Services (CMS) imposed a 6-month nationwide moratorium on new Medicare enrollments for hospice agencies and home health agencies (HHAs). At the same time, the agency suspended payments to hundreds of suspected fraudulent providers in Los Angeles, deferred $1.3 billion in Medicaid payments to California, and ordered a 50-state audit of provider revalidation.
CMS Administrator Dr. Mehmet Oz also previewed a Medicare GLP-1 Bridge program that caps weight-loss drug costs at $50 per month for eligible Part D enrollees starting July 1, 2026.
The short answer
On May 13, 2026, the Centers for Medicare and Medicaid Services (CMS) imposed a 6-month nationwide moratorium on new Medicare enrollments for hospice agencies and home health agencies (HHAs). At the same time, the agency suspended payments to hundreds of suspected fraudulent providers in Los Angeles, deferred $1.3 billion in Medicaid payments to California, and ordered a 50-state audit of provider revalidation. CMS Administrator Dr. Mehmet Oz also previewed a Medicare GLP-1 Bridge program that caps weight-loss drug costs at $50 per month for eligible Part D enrollees starting July 1, 2026.
Why CMS is freezing new hospice and home health enrollments
The hospice and home health sectors have been flagged for years as high-risk environments for Medicare fraud, particularly in states like California, Texas, Nevada, and Arizona. Patterns include phantom patients, ineligible certifications of terminal illness, and clusters of suddenly-formed agencies sharing addresses or staff.
The 6-month moratorium does three things at once:
- Stops the inflow. CMS will not accept or process new Medicare enrollment applications for hospice agencies or HHAs nationwide, including in Washington, D.C. and U.S. territories.
- Buys investigation time. The agency plans to use the window to deploy advanced data analytics and run targeted audits of existing providers.
- Closes geographic loopholes. A nationwide freeze prevents bad actors from simply relocating across state lines to dodge a state-level pause.
Existing legitimate providers can continue billing and operating as usual. The freeze only affects new enrollment applications, not patient care from already-enrolled agencies.
The California Medicaid payment deferral
The fight escalated dramatically with California. CMS recently suspended payments to roughly 773 hospices and 23 home health agencies in the Los Angeles area suspected of fraud, freezing more than $70 million in funds. Vice President JD Vance, leading the administration's Anti-Fraud Task Force, then announced that an additional $1.3 billion in Medicaid payments to California would be deferred over broader fraud and oversight concerns.
California Governor Gavin Newsom condemned the move as politically motivated and warned that withholding such a large amount risks collateral damage to legitimate providers, safety-net hospitals, and vulnerable patients who rely on Medi-Cal services. The dispute is now both a fraud enforcement story and a federalism flashpoint.
The 50-state Medicaid audit
Dr. Oz also announced that all 50 states must submit detailed plans for how they will revalidate their Medicaid providers. States have 30 days to respond. Plans are expected to cover:
- How they verify provider identities and ownership chains.
- How they detect billing anomalies and shell companies.
- How they coordinate with federal data systems for provider screening.
Oz warned that states that fail to submit credible plans could face more aggressive federal audits and potential payment actions similar to those now in play in California.
The Medicare GLP-1 Bridge program
Amid the enforcement push, CMS also unveiled a major win for beneficiaries. Beginning July 1, 2026, the Medicare GLP-1 Bridge program will offer eligible Medicare Part D enrollees access to GLP-1 weight-loss medications for a capped $50 per month supply. Key points:
- It is a time-limited demonstration, not a permanent benefit expansion.
- Eligibility will focus on beneficiaries who meet specific clinical criteria (such as obesity with comorbidities).
- The $50 cap is designed to remove the price barrier that has kept GLP-1 drugs out of reach for many seniors despite their proven cardiometabolic benefits.
What this means for providers and patients
For legitimate hospice and home health agencies, the immediate impact is operational rather than financial: existing operations continue, but expansion plans involving new entities are paused. For any provider with billing irregularities, expect intensified scrutiny.
For patients, current hospice and home health services are not interrupted by the moratorium. The bigger consumer story is the GLP-1 Bridge, which could meaningfully change how Medicare patients access weight-loss therapies starting in July.
Frequently Asked Questions (FAQ)
How long is the CMS hospice enrollment moratorium?
It is a 6-month nationwide moratorium beginning May 13, 2026, applied to both hospice agencies and home health agencies.
Does the moratorium stop care for existing patients?
No. Already-enrolled providers can continue billing and serving patients. The freeze applies only to new Medicare enrollment applications.
How much Medicaid funding has been deferred from California?
$1.3 billion in Medicaid payments has been deferred, on top of more than $70 million in suspended payments to suspected fraudulent hospices and home health agencies in the Los Angeles area.
What is the Medicare GLP-1 Bridge program?
A time-limited Medicare Part D demonstration starting July 1, 2026, that caps eligible enrollees' cost for GLP-1 weight-loss medications at $50 per monthly supply.
The takeaway
This is the most aggressive coordinated CMS fraud enforcement push in years: a national enrollment freeze, billions deferred from a single state, and a 50-state audit running in parallel. The political fight with California will dominate headlines, but the GLP-1 Bridge is the policy that will most directly affect everyday Medicare patients.
Quick recap
CMS imposed a 6-month nationwide moratorium on new hospice and home health Medicare enrollments, suspended payments to hundreds of suspected fraudulent providers in Los Angeles, deferred $1.3 billion in California Medicaid payments, and ordered a 50-state Medicaid audit. The GLP-1 Bridge program will cap eligible weight-loss drug costs at $50 per month starting July 1, 2026.
